Clinical Trial Update: A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports completion of a study evaluating danoprevir/ritonavir and ribavirin with RO5024048 and/or Pegasys in patients with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Danoprevir/ritonavir (danoprevir/ritonavir)
• Pegasys (pegylated interferon alfa-2a)
• RO5024048

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED